UCBJY Projected Dividend Yield
ADR/UCB S.A. ( OTCBB : UCBJY )UCB is a global biopharmaceutical company focused on severe diseases in two therapeutic areas, namely central nervous system disorders and immunology. In the area of central nervous system disorders, Co. is focused on advanced Parkinson's disease, epilepsy, restless legs syndrome and epilepsy. In the area of immunology disorders, Co. is focused on rheumatoid arthritis, axial spondyloarthritis, psoriatic arthritis, systemic lupus erythematosus, juvenile idiopathic arthritis, post-menopausal osteoporosis, systemic lupus erythematosus and immunological diseases. 25 YEAR PERFORMANCE RESULTS |
UCBJY Dividend History Detail UCBJY Dividend News UCBJY Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
2024 |
N/A |
Apr 26, 2024 |
Apr 29, 2024 |
May 15, 2024 |
0.4596 |
2024 Total: |
0.4596 |
||||
2023 |
N/A |
May 01, 2023 |
May 02, 2023 |
May 18, 2023 |
0.4624 |
2023 Total: |
0.4624 |
||||
2022 |
N/A |
Apr 29, 2022 |
May 02, 2022 |
May 18, 2022 |
0.4291 |
2022 Total: |
0.4291 |
||||
2021 |
N/A |
May 07, 2021 |
May 10, 2021 |
May 19, 2021 |
0.4838 |
2021 Total: |
0.4838 |
||||
2020 |
N/A |
May 04, 2020 |
May 05, 2020 |
May 21, 2020 |
0.4184 |
2020 Total: |
0.4184 |